How does the body regulate the activity of insulin-producing cells in order to react quickly to changing conditions? Researchers have investigated this question.

The hormone insulin plays a central role in the metabolism of many living organisms. When food is plentiful, insulin promotes ...

We expect Novo to gain $75 billion of a more than $200 billion global GLP-1 market in diabetes and obesity by 2031, ahead of semaglutide's 2032 patent expiration, with Lilly standing as the firm's key ...

Second, DexCom has expanded its product offerings. Last year, it launched Stelo in the U.S., an over-the-counter CGM option that can be used by pre-diabetes patients. This initiative significantly ...

An estimated 42 million people in India suffer from thyroid problems, an autoimmune condition that has grown very common. The most frequent cause is thought to be iodine deficiency brought on by ...

Salk Institute researchers have identified a key protein that may help users of GLP-1 drugs such as Ozempic and Wegovy ...

Dr. Jaishree Sharad talks about how one should limit the use of sugar rather than cheating themselves by having so-called ...

A high-sugar diet may increase the risk of weight gain, obesity, cancer, and potentially accelerate tumor growth.

When you're buying income stocks, a company's underlying business is arguably still the most crucial factor to consider, even more than the dividend yield. Which dividend-paying companies should ...

About one in eight adults in the United States has tried or currently uses a GLP-1 medication, and a quarter of those users cite weight loss as their main goal.

With the recent surge in popularity of weight loss drugs like Ozempic, altogether called GLP-1s, there has been renewed scientific interest in understanding how our bodies regulate muscle growth.

About one in eight adults in the United States has tried or currently uses a GLP-1 medication, and a quarter of those users ...